Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 177 (RNA5SP177) is classified as a pseudogene and annotated in the human genome as a non-functional, non-coding derivative of the 5S ribosomal RNA gene family[6][4]. Pseudogenes like RNA5SP177 typically arise via duplication or retrotransposition events and accumulate mutations that abolish their original function[2]. As a processed or duplicated pseudogene, RNA5SP177 does not encode functional 5S rRNA and lacks protein-coding or regulatory roles attributed to its parental gene family. There is no evidence for its involvement in normal physiology, disease, or therapeutic intervention.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 177 (RNA5SP177).